phosphorylcholine has been researched along with Lung Diseases in 21 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
Lung Diseases: Pathological processes involving any part of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pulmonary hemorrhage was present in 55% of 159 infants undergoing autopsy; the incidence was not different in infants treated with surfactant or air placebo." | 2.67 | Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. ( Derleth, D; Finer, N; Long, W; McMurray, B; Mullett, M; Peliowski, A; Sankaran, K; van Houten, J; Walker, D; Wold, D, 1992) |
| "Pulmonary hemorrhage was defined by an onset of bright red blood from the endotracheal tube in quantities that resulted in increased ventilatory support and a new infiltrate on a chest radiograph." | 1.29 | Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study. ( Buck, R; Garland, J; Weinberg, M, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (95.24) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahadue, FL | 1 |
| Soll, R | 1 |
| Strüber, M | 1 |
| Cremer, J | 1 |
| Harringer, W | 1 |
| Hirt, SW | 1 |
| Costard-Jäckle, A | 1 |
| Haverich, A | 1 |
| Huang, YC | 2 |
| Sane, AC | 1 |
| Simonson, SG | 1 |
| Fawcett, TA | 1 |
| Moon, RE | 1 |
| Fracica, PJ | 2 |
| Menache, MG | 1 |
| Piantadosi, CA | 2 |
| Young, SL | 2 |
| Duhaylongsod, FG | 1 |
| Welty-Wolf, KE | 1 |
| Crapo, JD | 1 |
| Findlay, RD | 1 |
| Taeusch, HW | 1 |
| David-Cu, R | 1 |
| Walther, FJ | 2 |
| Mullett, M | 2 |
| Schumacher, R | 1 |
| Sundell, H | 1 |
| Easa, D | 2 |
| Long, W | 8 |
| Sell, M | 1 |
| Cotton, R | 1 |
| Hirata, T | 1 |
| Guthrie, R | 1 |
| LeBlanc, M | 1 |
| Mammel, M | 1 |
| Gerdes, J | 2 |
| Gerdes, M | 1 |
| Beaumont, E | 1 |
| Cook, L | 1 |
| Dhanireddy, R | 1 |
| Kopleman, A | 1 |
| Jarret, R | 1 |
| Gong, A | 1 |
| Anday, E | 1 |
| Boros, S | 2 |
| Bucciarelli, R | 1 |
| Burchfield, D | 1 |
| Zucker, J | 1 |
| Sauve, R | 1 |
| Vincer, M | 1 |
| Bard, H | 2 |
| Derleth, D | 2 |
| Stevenson, D | 1 |
| Pauly, T | 1 |
| Robertson, C | 1 |
| McMillan, D | 2 |
| Chernick, V | 1 |
| Finer, N | 2 |
| Schiff, D | 2 |
| Watts, J | 1 |
| Krzeski, R | 1 |
| Garland, J | 1 |
| Buck, R | 1 |
| Weinberg, M | 1 |
| Sherman, MP | 1 |
| Campbell, LA | 1 |
| Merritt, TA | 1 |
| Long, WA | 1 |
| Gunkel, JH | 1 |
| Curstedt, T | 1 |
| Robertson, B | 1 |
| Majeed-Saidan, MA | 1 |
| al-Hifzi, I | 1 |
| Khan, M | 1 |
| Rogers, D | 1 |
| Abbasi, S | 1 |
| Bhutani, VK | 1 |
| Gerdes, JS | 1 |
| Balaraman, V | 1 |
| Meister, J | 1 |
| Ku, TL | 1 |
| Sood, SL | 1 |
| Tam, E | 1 |
| Killeen, J | 1 |
| Uyehara, CF | 1 |
| Egan, E | 1 |
| Bhatt-Mehta, V | 1 |
| Schumacher, RE | 1 |
| van Houten, J | 1 |
| McMurray, B | 1 |
| Peliowski, A | 1 |
| Walker, D | 1 |
| Wold, D | 1 |
| Sankaran, K | 1 |
| Corbet, A | 1 |
| Allen, A | 1 |
| Vaughan, R | 1 |
| Houle, L | 1 |
| Edwards, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pulse Oximetry With Clinical Observation to Screen for Lung Disease in Neonates[NCT02533583] | 15,000 participants (Anticipated) | Observational | 2015-11-30 | Active, not recruiting | |||
| Lung UltrasouNd Guided Surfactant Therapy in Preterm Infants: an International Multicentric Randomized Control Trial (LUNG Study)[NCT05198375] | 668 participants (Anticipated) | Interventional | 2022-04-05 | Recruiting | |||
| Comparison of Two Different Natural Surfactants in the Treatment of Pulmonary Hemorrhage[NCT01860014] | 20 participants (Actual) | Interventional | 2010-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for phosphorylcholine and Lung Diseases
| Article | Year |
|---|---|
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Topics: Acute Disease; Acute Lung Injury; Chronic Disease; Drug Combinations; Fatty Alcohols; Humans; Infant | 2012 |
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Topics: Acute Disease; Acute Lung Injury; Chronic Disease; Drug Combinations; Fatty Alcohols; Humans; Infant | 2012 |
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Topics: Acute Disease; Acute Lung Injury; Chronic Disease; Drug Combinations; Fatty Alcohols; Humans; Infant | 2012 |
Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Topics: Acute Disease; Acute Lung Injury; Chronic Disease; Drug Combinations; Fatty Alcohols; Humans; Infant | 2012 |
10 trials available for phosphorylcholine and Lung Diseases
10 other studies available for phosphorylcholine and Lung Diseases
| Article | Year |
|---|---|
Nebulized synthetic surfactant in reperfusion injury after single lung transplantation.
Topics: Adult; Aerosols; Drug Combinations; Fatty Alcohols; Female; Humans; Lung Diseases; Lung Transplantat | 1995 |
Artificial surfactant attenuates hyperoxic lung injury in primates. I. Physiology and biochemistry.
Topics: Animals; Drug Combinations; Enzyme-Linked Immunosorbent Assay; Fatty Alcohols; Hemodynamics; Lung Di | 1995 |
Artificial surfactant attenuates hyperoxic lung injury in primates. II. Morphometric analysis.
Topics: Aerosols; Animals; Blood Gas Analysis; Cell Division; Drug Combinations; Endothelium; Fatty Alcohols | 1995 |
Lysis of red blood cells and alveolar epithelial toxicity by therapeutic pulmonary surfactants.
Topics: Animals; Biological Products; Drug Combinations; Epithelial Cells; Epithelium; Fatty Alcohols; Hemol | 1995 |
Pulmonary hemorrhage risk in infants with a clinically diagnosed patent ductus arteriosus: a retrospective cohort study.
Topics: Cohort Studies; Drug Combinations; Ductus Arteriosus, Patent; Fatty Alcohols; Female; Hemorrhage; Hu | 1994 |
Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits.
Topics: Animals; Animals, Newborn; Biological Products; Cell Division; Drug Combinations; Fatty Alcohols; Lu | 1994 |
Pulmonary haemorrhage in low-birthweight babies.
Topics: Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Hyaline Membrane Disease; Infant, Low Birth W | 1993 |
Pulmonary haemorrhage, surfactant, and low-birthweight babies.
Topics: Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Infant, Low Birth Weight; Infant, Newborn; Lu | 1993 |
Lavage administration of dilute surfactants after acute lung injury in neonatal piglets.
Topics: Animals; Animals, Newborn; Bronchoalveolar Lavage; Disease Models, Animal; Drug Combinations; Fatty | 1998 |
Criteria for use of colfosceril (Exosurf) in neonates.
Topics: Apnea; Drug Combinations; Fatty Alcohols; Hemorrhage; Humans; Infant, Newborn; Intubation, Intratrac | 1992 |